Your browser doesn't support javascript.
loading
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.
James, Katherine; Al-Ali, Shereen; Tarn, Jessica; Cockell, Simon J; Gillespie, Colin S; Hindmarsh, Victoria; Locke, James; Mitchell, Sheryl; Lendrem, Dennis; Bowman, Simon; Price, Elizabeth; Pease, Colin T; Emery, Paul; Lanyon, Peter; Hunter, John A; Gupta, Monica; Bombardieri, Michele; Sutcliffe, Nurhan; Pitzalis, Costantino; McLaren, John; Cooper, Annie; Regan, Marian; Giles, Ian; Isenberg, David; Saravanan, Vadivelu; Coady, David; Dasgupta, Bhaskar; McHugh, Neil; Young-Min, Steven; Moots, Robert; Gendi, Nagui; Akil, Mohammed; Griffiths, Bridget; Wipat, Anil; Newton, Julia; Jones, David E; Isaacs, John; Hallinan, Jennifer; Ng, Wan-Fai.
Affiliation
  • James K; Interdisciplinary Computing and Complex BioSystems Research Group, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Al-Ali S; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Tarn J; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Cockell SJ; Department of Biology, College of Science, University of Basrah, Basrah, Iraq.
  • Gillespie CS; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Hindmarsh V; Bioinformatics Support Unit, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Locke J; School of Mathematics & Statistics, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Mitchell S; Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Lendrem D; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Bowman S; Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Price E; Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Pease CT; Rheumatology Department, University Hospital Birmingham, Birmingham, United Kingdom.
  • Emery P; Great Western Hospitals NHS Foundation Trust, Swindon, United Kingdom.
  • Lanyon P; Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust, Leeds, United Kingdom.
  • Hunter JA; Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust, Leeds, United Kingdom.
  • Gupta M; Nottingham University Hospital, Nottingham, United Kingdom.
  • Bombardieri M; Gartnavel General Hospital, Glasgow, United Kingdom.
  • Sutcliffe N; Gartnavel General Hospital, Glasgow, United Kingdom.
  • Pitzalis C; Barts and the London NHS Trust & Barts and the London School of Medicine and Dentistry, London, United Kingdom.
  • McLaren J; Barts and the London NHS Trust & Barts and the London School of Medicine and Dentistry, London, United Kingdom.
  • Cooper A; Barts and the London NHS Trust & Barts and the London School of Medicine and Dentistry, London, United Kingdom.
  • Regan M; NHS Fife, Whyteman's Brae Hospital, Kirkcaldy, United Kingdom.
  • Giles I; Royal Hampshire County Hospital, Winchester, United Kingdom.
  • Isenberg D; Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom.
  • Saravanan V; Royal Derby Hospital, Derby, United Kingdom.
  • Coady D; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Dasgupta B; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • McHugh N; Queen Elizabeth Hospital, Gateshead, United Kingdom.
  • Young-Min S; Sunderland Royal Hospital, Sunderland, United Kingdom.
  • Moots R; Southend University Hospital, Southend, United Kingdom.
  • Gendi N; Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom.
  • Akil M; Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom.
  • Griffiths B; Aintree University Hospitals, Liverpool, United Kingdom.
  • Wipat A; Royal Hallamshire Hospital, Sheffield, United Kingdom.
  • Newton J; Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Isaacs J; Interdisciplinary Computing and Complex BioSystems Research Group, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Hallinan J; Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Ng WF; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
PLoS One ; 10(12): e0143970, 2015.
Article in En | MEDLINE | ID: mdl-26694930
BACKGROUND: Fatigue is a debilitating condition with a significant impact on patients' quality of life. Fatigue is frequently reported by patients suffering from primary Sjögren's Syndrome (pSS), a chronic autoimmune condition characterised by dryness of the eyes and the mouth. However, although fatigue is common in pSS, it does not manifest in all sufferers, providing an excellent model with which to explore the potential underpinning biological mechanisms. METHODS: Whole blood samples from 133 fully-phenotyped pSS patients stratified for the presence of fatigue, collected by the UK primary Sjögren's Syndrome Registry, were used for whole genome microarray. The resulting data were analysed both on a gene by gene basis and using pre-defined groups of genes. Finally, gene set enrichment analysis (GSEA) was used as a feature selection technique for input into a support vector machine (SVM) classifier. Classification was assessed using area under curve (AUC) of receiver operator characteristic and standard error of Wilcoxon statistic, SE(W). RESULTS: Although no genes were individually found to be associated with fatigue, 19 metabolic pathways were enriched in the high fatigue patient group using GSEA. Analysis revealed that these enrichments arose from the presence of a subset of 55 genes. A radial kernel SVM classifier with this subset of genes as input displayed significantly improved performance over classifiers using all pathway genes as input. The classifiers had AUCs of 0.866 (SE(W) 0.002) and 0.525 (SE(W) 0.006), respectively. CONCLUSIONS: Systematic analysis of gene expression data from pSS patients discordant for fatigue identified 55 genes which are predictive of fatigue level using SVM classification. This list represents the first step in understanding the underlying pathophysiological mechanisms of fatigue in patients with pSS.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sjogren's Syndrome / Oligonucleotide Array Sequence Analysis / Fatigue / Transcriptome Type of study: Etiology_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sjogren's Syndrome / Oligonucleotide Array Sequence Analysis / Fatigue / Transcriptome Type of study: Etiology_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Type: Article Affiliation country: United kingdom